APA (7th ed.) Citation

S, R., J, R., H, U., A, C., E, P., AM, W., . . . C, T. (2023). Treatment with Helicobacter pylori-derived VacA attenuates allergic airway disease. Frontiers in immunology, 14, 1092801. https://doi.org/10.3389/fimmu.2023.1092801

Chicago Style (17th ed.) Citation

S, Reuter, et al. "Treatment with Helicobacter Pylori-derived VacA Attenuates Allergic Airway Disease." Frontiers in Immunology 14 (2023): 1092801. https://doi.org/10.3389/fimmu.2023.1092801.

MLA (9th ed.) Citation

S, Reuter, et al. "Treatment with Helicobacter Pylori-derived VacA Attenuates Allergic Airway Disease." Frontiers in Immunology, vol. 14, 2023, p. 1092801, https://doi.org/10.3389/fimmu.2023.1092801.